| Financial Year |
March 31 2023 |
| Monetary Funds |
1,221,429,625.90 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
498,611,475.67 |
| Accounts Receivable |
1,477,841,256.20 |
| Advances to Suppliers |
145,129,400.99 |
| Other Receivables |
147,683,658.09 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
551,786,918.86 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
76,886,382.89 |
| Total Current Assets |
4,425,769,551.82 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
139,503,496.25 |
| Investment Properties |
85,445,772.25 |
| Fixed Assetes |
1,923,796,128.43 |
| Under-construction Projects |
56,798,894.20 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,016,737,336.31 |
| R&D expenses |
-- |
| Goodwill |
862,113,201.57 |
| Long-Term Deferred and Prepaid Expenses |
18,369,830.16 |
| Deferred Income Tax Assets |
44,843,359.18 |
| Other Non-Current Assets |
31,834,725.35 |
| Sub-Total of Non-Current Assets |
4,588,698,892.49 |
| Total Assets |
9,014,468,444.31 |
| Short-Term Loans |
500,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
30,000,000.00 |
| Accounts Payable |
942,307,969.69 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
93,103,516.16 |
| Taxes Payable |
124,268,012.07 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
253,503,499.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
150,879,611.20 |
| Other Current Liabilities |
352,512,829.77 |
| Sub-Total of Current Liabilities |
2,527,618,810.46 |
| Long-term Loans |
351,485,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
17,991,455.93 |
| Deferred Income Tax Liabilities |
163,300,637.19 |
| Other Non-Current Liabilities |
2,143,295.57 |
| Sub-Total of Non-Current Liabilities |
936,782,255.98 |
| Total Liabilities |
3,464,401,066.44 |
| Paid-In Capital(Or Share Stock) |
1,123,292,914.00 |
| Capital Surplus |
2,423,859,203.84 |
| Surplus Reserve |
334,390,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,318,699,241.60 |
| Minority Stockholder's Interest |
312,775,216.41 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,237,292,161.46 |
| Owner's Equity（Stockholder's Equity） |
5,550,067,377.87 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,014,468,444.31 |
